Form 8-K - Current report:
SEC Accession No. 0001213900-24-053828
Filing Date
2024-06-18
Accepted
2024-06-18 16:30:24
Documents
18
Period of Report
2024-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0208028-8k_longeve.htm   iXBRL 8-K 49156
2 FORM OF NEW WARRANT ea020802801ex4-1_long.htm EX-4.1 105171
3 FORM OF PLACEMENT AGENT WARRANT ea020802801ex4-2_long.htm EX-4.2 110639
4 FORM OF INDUCEMENT LETTER AGREEMENT, DATED JUNE 17, 2024, BY AND BETWEEN THE COM ea020802801ex10-1_long.htm EX-10.1 54713
5 PRESS RELEASE ISSUED BY THE COMPANY ON JUNE 17, 2024 ea020802801ex99-1_long.htm EX-99.1 13766
6 PRESS RELEASE ISSUED BY THE COMPANY ON JUNE 18, 2024 ea020802801ex99-2_long.htm EX-99.2 13441
  Complete submission text file 0001213900-24-053828.txt   611994

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE lgvn-20240617.xsd EX-101.SCH 3021
8 XBRL LABEL FILE lgvn-20240617_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE lgvn-20240617_pre.xml EX-101.PRE 22363
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0208028-8k_longeve_htm.xml XML 3801
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 241052281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)